A study of type of anaesthetic techniques in patients with acyanotic congenital heart diseases undergoing device closure
Not Applicable
- Conditions
- Health Condition 1: null- Patients with congenital acyanotic heart diseases undergoing device closure
- Registration Number
- CTRI/2017/11/010360
- Lead Sponsor
- okmanya Tilak Municipal Medical College and General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
All patients of above mentioned age group having acyanotic congenital heart disease undergoing device closure under general Anaesthesia
Exclusion Criteria
Haemodynamically unstable patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the safety of type of Anaesthesia in various defects like ASD VSD and PDA by studying the incidence of airway related complications like laryngospasm bronchospasm occurring intraoperatively or in the postoperative period and monitoring the incidence of device dislodgement related to anaesthesia technique induced complicationsTimepoint: 1 two minutes after injection of induction drug <br/ ><br>2 Airway related complications like laryngospasm, bronchospasm occurring within 30 to 60 seconds after intubation <br/ ><br>3 Incidence of device dislodgement occurring 5 min to 24 hours after placement of device
- Secondary Outcome Measures
Name Time Method Study of other device related complications like Arrhythmias, Perforation of major vessels, difficulty in placement of deviceTimepoint: Intraoperatively every ten minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie volatile vs. intravenous anesthetic effects in acyanotic CHD device closure?
How does propofol-based anesthesia compare to sevoflurane in hemodynamic stability for acyanotic CHD device closure?
Which biomarkers predict response to specific anesthetic techniques in acyanotic CHD patients undergoing device closure?
What are the incidence rates of arrhythmias during device closure under different anesthetic protocols in acyanotic CHD?
How do adjuvant drugs like remifentanil enhance anesthetic efficacy in acyanotic CHD device closure procedures?